Gregg Eure, MD

Articles by Gregg Eure, MD

Making Sense of the Reintervention Rate for BPH

ByGregg Eure, MD,LAURENCE A. LEVINE, MD

March 7th 2021

Letter: BPH guidelines may ignore FDA, insurance criteria

ByGregg Eure, MD

May 12th 2020

"As we seek to understand MIST retreatment rates, as Houlihan and Köhler suggest, we must rely upon real-world population data," writes Gregg Eure, MD, in a letter to the editor.

Latest Updated Articles

Making Sense of the Reintervention Rate for BPH
Published: March 7th 2021 | Updated:
Letter: BPH guidelines may ignore FDA, insurance criteria
Published: May 12th 2020 | Updated:

Gregg Eure, MD

Articles by Gregg Eure, MD

Making Sense of the Reintervention Rate for BPH

Letter: BPH guidelines may ignore FDA, insurance criteria

Latest Updated Articles

Trending on Urology Times

Beyond the clinic: Physician presence on social media

FDA updates in urology: December 2025

Daniel Spratt, MD, on using ArteraAI to guide salvage therapy decisions

Study validates Decipher as a predictor of early biochemical recurrence in prostate cancer

Permanent J code for mitomycin for intravesical solution now in effect